These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 19877975)
1. Effects of clonidine and methylphenidate on family quality of life in attention-deficit/hyperactivity disorder. Cannon M; Pelham WH; Sallee FR; Palumbo DR; Bukstein O; Daviss WB J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):511-7. PubMed ID: 19877975 [TBL] [Abstract][Full Text] [Related]
2. Treatment of ADHD in children with tics: a randomized controlled trial. Tourette's Syndrome Study Group Neurology; 2002 Feb; 58(4):527-36. PubMed ID: 11865128 [TBL] [Abstract][Full Text] [Related]
3. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. Palumbo DR; Sallee FR; Pelham WE; Bukstein OG; Daviss WB; McDERMOTT MP; J Am Acad Child Adolesc Psychiatry; 2008 Feb; 47(2):180-188. PubMed ID: 18182963 [TBL] [Abstract][Full Text] [Related]
4. A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Connor DF; Barkley RA; Davis HT Clin Pediatr (Phila); 2000 Jan; 39(1):15-25. PubMed ID: 10660814 [TBL] [Abstract][Full Text] [Related]
5. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder. Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198 [TBL] [Abstract][Full Text] [Related]
9. A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. Rösler M; Fischer R; Ammer R; Ose C; Retz W Eur Arch Psychiatry Clin Neurosci; 2009 Mar; 259(2):120-9. PubMed ID: 19165529 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study. Wigal SB; Nordbrock E; Adjei AL; Childress A; Kupper RJ; Greenhill L CNS Drugs; 2015 Apr; 29(4):331-40. PubMed ID: 25877989 [TBL] [Abstract][Full Text] [Related]
11. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study. Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622 [TBL] [Abstract][Full Text] [Related]
12. Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial. Efron D; Jarman F; Barker M Pediatrics; 1997 Dec; 100(6):E6. PubMed ID: 9382907 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tipepidine as adjunctive therapy in children with attention-deficit/hyperactivity disorder: Randomized, double-blind, placebo-controlled clinical trial. Dehbozorghi S; Bagheri S; Moradi K; Shokraee K; Mohammadi MR; Akhondzadeh S Psychiatry Clin Neurosci; 2019 Nov; 73(11):690-696. PubMed ID: 31294924 [TBL] [Abstract][Full Text] [Related]
14. Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder. Spencer TJ; Greenbaum M; Ginsberg LD; Murphy WR J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):501-10. PubMed ID: 19877974 [TBL] [Abstract][Full Text] [Related]
15. Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study. Baziar S; Aqamolaei A; Khadem E; Mortazavi SH; Naderi S; Sahebolzamani E; Mortezaei A; Jalilevand S; Mohammadi MR; Shahmirzadi M; Akhondzadeh S J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):205-212. PubMed ID: 30741567 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder. Pliszka SR; Wilens TE; Bostrom S; Arnold VK; Marraffino A; Cutler AJ; López FA; DeSousa NJ; Sallee FR; Incledon B; Newcorn JH J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):474-482. PubMed ID: 29172680 [TBL] [Abstract][Full Text] [Related]
17. Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial. Zeni CP; Tramontina S; Ketzer CR; Pheula GF; Rohde LA J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):553-61. PubMed ID: 19877980 [TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder. Findling RL; Bukstein OG; Melmed RD; López FA; Sallee FR; Arnold LE; Pratt RD J Clin Psychiatry; 2008 Jan; 69(1):149-59. PubMed ID: 18312050 [TBL] [Abstract][Full Text] [Related]
19. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371]. Akhondzadeh S; Mohammadi MR; Khademi M BMC Psychiatry; 2004 Apr; 4():9. PubMed ID: 15070418 [TBL] [Abstract][Full Text] [Related]
20. Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy. May DE; Kratochvil CJ Drugs; 2010; 70(1):15-40. PubMed ID: 20030423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]